9 March 2021 - Shield Therapeutics notes that Australia’s Therapeutic Goods Administration has registered Feraccru in the Australian Register of ...
10 March 2021 - Onasemnogene abeparvovec is a new gene therapy for children with spinal muscular atrophy. ...
5 March 2021 - TGA has adopted guidance developed by the Access Consortium - a coalition of regulatory authorities from ...
24 February 2021 - Adjunct Professor John Skerritt has tasked the nation’s medical regulator with ensuring COVID-19 tests are successfully ...
18 February 2021 - From 25 February 2021, the way that software-based medical devices are regulated in Australia will change. ...
16 February 2021 - Medicines Australia welcomes the TGA’s decision granting provisional approval of the AstraZeneca/Oxford University COVID-19 vaccine, marking ...
16 February 2021 - The Therapeutic Goods Administration has granted provisional approval to AstraZeneca for its COVID-19 vaccine, making it ...
16 February 2021 - The TGA thinks glatiramer acetate (Glatopa) is a new chemical entity. ...
15 February 2021 - A proposal for a state-of-the-art $1 billion facility to manufacture vaccines and prescription drugs in Australia ...
11 February 2021 - Coronavirus vaccines are a step closer to arriving in Australia after the European Commission formally approved ...
11 February 2021 - CSL is confident it can make an updated version of AstraZeneca’s COVID-19 vaccine to cover any ...
9 February 2021 - Europe will not delay the first doses of Pfizer vaccine bound for Australia despite moves to block ...
8 February 2021 - Australians will have access to their COVID-19 immunisation certificates within days of receiving the vaccine, with ...
8 February 2021 - Australia, through the TGA, is one of only five non-European Union regulators formally invited to participate ...
4 February 2021 - The Therapeutic Goods Administration is conducting a public consultation that seeks to understand potential obstacles and ...